| |
| |
|
| Insider
Information: |
Raines Merilee |
| Relationship: |
|
| City: |
Westbrook |
| State: |
ME |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
93,212 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$19,918,480 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
93,212 |
|
|
| Total
Value |
$19,918,480 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idexx Laboratories Inc |
IDXX |
Executive VP & CFO |
2013-02-25 |
26,577 |
2013-02-01 |
0 |
Premium* |
|
|
Watts Industries Inc |
WTS |
Director |
2023-07-31 |
20,020 |
2011-03-01 |
0 |
Premium* |
|
|
Affymetrix Inc |
AFFX |
Director |
2016-03-31 |
0 |
2015-05-13 |
0 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2019-07-18 |
0 |
2016-06-24 |
0 |
Premium* |
|
|
Benchmark Electronics Inc |
BHE |
Director |
2021-05-12 |
24,489 |
2019-05-15 |
0 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
Director |
2023-06-14 |
20,933 |
2022-06-16 |
0 |
Premium* |
|
|
Transmedics Group, Inc. |
TMDX |
|
2023-05-25 |
1,193 |
2023-05-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-25 |
4 |
OE |
$34.37 |
$845,700 |
D/D |
15,871 |
26,577 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(18,000) |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
• – – |
2008-08-22 |
4 |
S |
$57.34 |
$1,204,039 |
D/D |
(21,000) |
124,807 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
• – – |
2009-08-12 |
4 |
S |
$50.75 |
$1,065,824 |
D/D |
(21,000) |
144,502 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
VP & CFO |
• – – |
2005-05-04 |
4 |
S |
$57.50 |
$1,241,987 |
D/D |
(21,600) |
28,200 |
|
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2011-08-12 |
4 |
OE |
$13.32 |
$319,560 |
D/D |
24,000 |
195,294 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2012-11-06 |
4 |
S |
$93.84 |
$2,346,118 |
D/D |
(25,000) |
146,021 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-01-31 |
4 |
S |
$95.46 |
$2,997,309 |
I/I |
(31,375) |
35,000 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2010-08-10 |
4 |
S |
$59.02 |
$1,859,051 |
D/D |
(31,500) |
169,981 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
VP & CFO |
• – – |
2005-05-04 |
4 |
OE |
$22.50 |
$767,250 |
D/D |
34,100 |
49,800 |
|
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-01 |
4 |
S |
$94.74 |
$3,322,369 |
I/I |
(35,000) |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
• – – |
2008-08-22 |
4 |
OE |
$12.25 |
$490,000 |
D/D |
40,000 |
145,807 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate Vice President & CFO |
• – – |
2009-08-12 |
4 |
OE |
$8.84 |
$353,752 |
D/D |
40,000 |
165,502 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-01 |
4 |
S |
$94.41 |
$4,889,380 |
D/D |
(51,581) |
0 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-01-31 |
4 |
S |
$95.27 |
$5,252,314 |
D/D |
(55,076) |
38,000 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Corporate VP & CFO |
• – – |
2010-08-10 |
4 |
OE |
$11.34 |
$666,792 |
D/D |
56,000 |
201,481 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-04 |
4 |
S |
$93.63 |
$8,369,089 |
D/D |
(89,348) |
9,800 |
0 |
- |
|
| IDXX |
Idexx Laboratories Inc |
Executive VP & CFO |
• – – |
2013-02-04 |
4 |
OE |
$25.45 |
$3,877,167 |
D/D |
99,148 |
99,148 |
0 |
- |
|
93 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
